Business Context and Reporting Period
This Form 8-K Current Report was filed by Puma Biotechnology, Inc. on December 13, 2021, covering the event date of December 9, 2021. The filing addresses corporate governance changes rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 5.02 regarding officer and director departures.
Material Changes
The material change reported is the resignation of Ann Miller from the Board of Directors, effective December 31, 2021. The Company explicitly states that the resignation is not the result of any disagreement with the Company.
Guidance, Outlook, and Risks
The filing contains no management commentary on financial guidance, future outlook, risks, contingencies, or unusual items.
Investor Verification Checklist
- Confirm the effective date of Ann Miller's resignation (December 31, 2021).
- Verify the status of the Board of Directors following this departure.
- Review subsequent filings for any appointment of a replacement director.